FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308485502> ?p ?o ?g. }

• W4308485502 endingPage "238" @default.
• W4308485502 startingPage "224" @default.
• W4308485502 abstract "Treatment of many cancers, particularly those that remain difficult to treat or are refractive after standard-of-care therapies, has been challenging with cell-based therapies. Although relatively safe as allogeneic therapies and innately effective against cancers without the need for antigen sensitization, natural killer (NK) cells have necessitated use of genetic manipulation approaches to enhance their specificity, persistence, and homing. Chimeric antigen receptor (CAR) and gene-edited NK cell therapies have emerged as a potent treatment modality, addressing many of the issues that have plagued such gene-based therapies with other cell types. Early examples of engineered NK cell therapies have largely leveraged their activity against hematological malignancies in combination with conventional construct architectures or by editing putative genetic targets of immunosuppression. As the motivation to tackle more complex solid tumors grows, so has the sophistication and emergence of NK-specific constructs and engineering approaches. Multi-CARs, combinations with diverse genome editing technologies, as well as responsive and sensing CARs have appeared in the context of NK cell therapy. Here we discuss engineering approaches for NK cell therapy, the latest developments in the field, and what stands in the way of those promises en route to clinical translation. Treatment of many cancers, particularly those that remain difficult to treat or are refractive after standard-of-care therapies, has been challenging with cell-based therapies. Although relatively safe as allogeneic therapies and innately effective against cancers without the need for antigen sensitization, natural killer (NK) cells have necessitated use of genetic manipulation approaches to enhance their specificity, persistence, and homing. Chimeric antigen receptor (CAR) and gene-edited NK cell therapies have emerged as a potent treatment modality, addressing many of the issues that have plagued such gene-based therapies with other cell types. Early examples of engineered NK cell therapies have largely leveraged their activity against hematological malignancies in combination with conventional construct architectures or by editing putative genetic targets of immunosuppression. As the motivation to tackle more complex solid tumors grows, so has the sophistication and emergence of NK-specific constructs and engineering approaches. Multi-CARs, combinations with diverse genome editing technologies, as well as responsive and sensing CARs have appeared in the context of NK cell therapy. Here we discuss engineering approaches for NK cell therapy, the latest developments in the field, and what stands in the way of those promises en route to clinical translation." @default.
• W4308485502 created "2022-11-12" @default.
• W4308485502 creator A5021984184 @default.
• W4308485502 creator A5060184925 @default.
• W4308485502 date "2022-12-01" @default.
• W4308485502 modified "2023-10-18" @default.
• W4308485502 title "Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy" @default.
• W4308485502 cites W109340176 @default.
• W4308485502 cites W1166263056 @default.
• W4308485502 cites W15361604 @default.
• W4308485502 cites W1722231891 @default.
• W4308485502 cites W1800095175 @default.
• W4308485502 cites W1950063835 @default.
• W4308485502 cites W1954860593 @default.
• W4308485502 cites W1955255689 @default.
• W4308485502 cites W1986856090 @default.
• W4308485502 cites W2002125829 @default.
• W4308485502 cites W2010303814 @default.
• W4308485502 cites W2016523043 @default.
• W4308485502 cites W2018325561 @default.
• W4308485502 cites W2025141198 @default.
• W4308485502 cites W2027053879 @default.
• W4308485502 cites W2027470770 @default.
• W4308485502 cites W2036386987 @default.
• W4308485502 cites W2040896021 @default.
• W4308485502 cites W2050632372 @default.
• W4308485502 cites W2056315817 @default.
• W4308485502 cites W2057686712 @default.
• W4308485502 cites W2058075271 @default.
• W4308485502 cites W2059134148 @default.
• W4308485502 cites W2062167821 @default.
• W4308485502 cites W2067367325 @default.
• W4308485502 cites W2072015736 @default.
• W4308485502 cites W2077217249 @default.
• W4308485502 cites W2081047303 @default.
• W4308485502 cites W2087654677 @default.
• W4308485502 cites W2092166052 @default.
• W4308485502 cites W2094651511 @default.
• W4308485502 cites W2096244608 @default.
• W4308485502 cites W2097050852 @default.
• W4308485502 cites W2098799914 @default.
• W4308485502 cites W2103801996 @default.
• W4308485502 cites W2108696118 @default.
• W4308485502 cites W2110999048 @default.
• W4308485502 cites W2111411380 @default.
• W4308485502 cites W2123046879 @default.
• W4308485502 cites W2124416339 @default.
• W4308485502 cites W2126153224 @default.
• W4308485502 cites W2132835748 @default.
• W4308485502 cites W2147090630 @default.
• W4308485502 cites W2157268148 @default.
• W4308485502 cites W2163255830 @default.
• W4308485502 cites W2168605307 @default.
• W4308485502 cites W2171669261 @default.
• W4308485502 cites W2175452743 @default.
• W4308485502 cites W2192976324 @default.
• W4308485502 cites W2227843001 @default.
• W4308485502 cites W2311158642 @default.
• W4308485502 cites W2319745661 @default.
• W4308485502 cites W2331962566 @default.
• W4308485502 cites W2397169494 @default.
• W4308485502 cites W2399278955 @default.
• W4308485502 cites W2414292758 @default.
• W4308485502 cites W2415485186 @default.
• W4308485502 cites W2464914168 @default.
• W4308485502 cites W2488076079 @default.
• W4308485502 cites W2519020116 @default.
• W4308485502 cites W2531805832 @default.
• W4308485502 cites W2556149828 @default.
• W4308485502 cites W2559827832 @default.
• W4308485502 cites W2589601152 @default.
• W4308485502 cites W2589601657 @default.
• W4308485502 cites W2608365863 @default.
• W4308485502 cites W2618174085 @default.
• W4308485502 cites W2626153771 @default.
• W4308485502 cites W2725187299 @default.
• W4308485502 cites W2738977754 @default.
• W4308485502 cites W2744273874 @default.
• W4308485502 cites W2770028022 @default.
• W4308485502 cites W2777010483 @default.
• W4308485502 cites W2782567278 @default.
• W4308485502 cites W2791408070 @default.
• W4308485502 cites W2885329899 @default.
• W4308485502 cites W2890799178 @default.
• W4308485502 cites W2890885475 @default.
• W4308485502 cites W2896565106 @default.
• W4308485502 cites W2899022735 @default.
• W4308485502 cites W2899703055 @default.
• W4308485502 cites W2902681328 @default.
• W4308485502 cites W2907940426 @default.
• W4308485502 cites W2921717903 @default.
• W4308485502 cites W2922879840 @default.
• W4308485502 cites W2923120491 @default.
• W4308485502 cites W2941417604 @default.
• W4308485502 cites W2947017746 @default.
• W4308485502 cites W2948485623 @default.
• W4308485502 cites W2949255414 @default.
• W4308485502 cites W2954370385 @default.

• next